Clinical Trial Update: Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy

View source ↗

Summary

This observational safety study is recruiting to monitor outcomes in women with neuromyelitis optica spectrum disorder who were exposed to UPLIZNA during pregna…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorder

Drugs mentioned

• Uplizna (inebilizumab)

Snippet

Sponsor: Amgen | Conditions: Neuromyelitis Optica Spectrum Disorder, Pregnancy Related | Status: RECRUITING